Regular Article
Molecular Cloning and Characterization of Human PDE8B, a Novel Thyroid-Specific Isozyme of 3′,5′-Cyclic Nucleotide Phosphodiesterase,☆☆

https://doi.org/10.1006/bbrc.1998.9379Get rights and content

Abstract

We have identified a novel human isozyme of 3′,5′-cyclic nucleotide phosphodiesterase (PDE), which we designated PDE8B. cDNA of 2844 bp encoding the C-terminal 659 amino acids of PDE8B was cloned following the identification of an expressed sequence tag (EST) obtained through a search of the EST database. The predicted protein sequences of PDE8B showed highest homology (65% identity, 83% similarity) to that of PDE8A. Northern blot analysis indicated that the mRNA encoding PDE8B is expressed specifically and abundantly in thyroid gland as a ∼4.2 kb mRNA, in contrast to the wide expression of PDE8A mRNA in various tissues. The carboxyl-terminal 584 amino acids of PDE8B were expressed inE.colias a fusion protein. The recombinant PDE8B exhibited cAMP PDE activity which was not inhibited by various PDE inhibitors including vinpocetine, milrinone, rolipram, and IBMX with the exception of dipyridamole which caused 50% inhibition at a concentration of 40 μM. cAMP hydrolytic activity was unaffected by cGMP and no cGMP PDE hydrolysis were detectable at concentrations up to 100 μM. These findings suggest that PDE8B is a new member of the PDE8 family.

References (19)

  • M.D. Houslay et al.

    Trends in Biochem. Sci.

    (1997)
  • D.A. Fisher et al.

    Biochem. Biophys. Res. Commun.

    (1998)
  • D.A. Fisher et al.

    J. Biol. Chem.

    (1998)
  • S.H. Soderling et al.

    J. Biol. Chem.

    (1998)
  • V.C. Manganiello et al.

    Arch. Biochem. Biophys.

    (1995)
  • S.F. Altschul et al.

    J. Mol. Biol.

    (1990)
  • M.A. Frohman

    Methods Enzymol.

    (1993)
  • M. Kozak

    Cell

    (1986)
  • S.L. Jin et al.

    J. Biol. Chem.

    (1992)
There are more references available in the full text version of this article.

Cited by (121)

  • The synthesis and biological evaluation of nucleobases/tetrazole hybrid compounds: A new class of phosphodiesterase type 3 (PDE3) inhibitors

    2020, Bioorganic and Medicinal Chemistry
    Citation Excerpt :

    The most important interactions between the synthesized compounds and the PDE3A are the purine-2NH interaction with Asp26, carbonyl ‘O’ of purine ring with His58 and tetrazole-H with Gln190. Moreover, purine-7NH interacts with His29 and purine-2NH interacts with Asp139. There are a few greasy amino acids, like Ile157, Pro143, Phe193, Phe161, Phe178, Leu189 and Trp153 at the binding site, so this can provide an opportunity for hydrophobic interactions with synthesized compounds.

  • Chaperones, somatotroph tumors and the cyclic AMP (cAMP)-dependent protein kinase (PKA) pathway

    2020, Molecular and Cellular Endocrinology
    Citation Excerpt :

    The rise of intracellular Ca2+ levels activates calmodulin, which initiates the transport and membrane fusion of GH storage vesicles (Anderson and Scanes, 2012; Frohman et al., 1999). One of the ways PKA's activation is terminated is by PDEs decreasing endogenous cAMP levels; the pituitary expresses PDE isoforms PDE2, PDE4, PDE8B, and PDE11A, of which PDE4 and PDE8B are cAMP-selective, whereas PDE2 and PDE11A hydrolyze both cAMP and cGMP (Peverelli et al., 2009a; Persani et al., 2001; Loughney et al., 2005; Hayashi et al., 1998). Intracellular cAMP levels are also lowered by the MRP family of cyclic nucleotide transporters.

  • Phosphodiesterases as therapeutic targets for respiratory diseases

    2019, Pharmacology and Therapeutics
    Citation Excerpt :

    As another cAMP-specific hydrolyzing PDE, PDE8, consisting of PDE8A and PDE8B, exhibits a higher-affinity and lower Km (≈0.04 - 0.15 μM) for cAMP compared to other PDE isoforms, thus acting as a potential drug target to shape low-level intracellular cAMP signals (Fisher, Smith, Pillar, St Denis, & Cheng, 1998; Hayashi et al., 1998; Soderling, Bayuga, & Beavo, 1998; Vang et al., 2010; Yan, Wang, Cai, & Ke, 2009). PDE8A is highly expressed in the testis, liver and heart (Fisher et al., 1998; Soderling et al., 1998), whereas PDE8B is richly found in the thyroid and brain (Hayashi et al., 1998). In the lung, both PDE8 isoforms have been detected, albeit the relevant expression levels are low.

View all citing articles on Scopus

The nucleotide and deduced amino acid sequences reported in this paper have been deposited with the GenBank/EMBL Data Bank under Accession No. AF079529.

☆☆

Abbreviations used: PDE, 3′, 5′ cyclic nucleotide phosphodiesterase; cAMP, adenosine 3′, 5′-cyclic monophosphate; cGMP, guanosine 3′, 5′-cyclic monophosphate; EST, expressed sequence tag; PCR, polymerase chain reaction; RACE, rapid amplification of cDNA ends; nt, nucleotide; bp, base pair; kb, kilobase; DMSO, dimethyl sulfoxide; IBMX, 3-isobutyl-1-methylxanthine; IC50, 50% inhibitory concentration

2

To whom correspondence should be addressed. Fax: 81-59-232-1765. E-mail:[email protected].

View full text